Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAuthor's Reply to Borg et al. Comment on: 'EU's New Pharmacovigilance Legislation: Considerations for Biosimilars'.AuthorsCalvo, BegoñaAbstractA response from the author of the article "EU's New Pharmacovigilance Legislation: Considerations for Biosimilars" published in the journal in 2013 is presented.SubjectsEUROPEAN Union countries; DRUG side effects laws; PHARMACEUTICAL industryPublicationDrug Safety, 2014, Vol 37, Issue 2, p125ISSN0114-5916Publication typeArticleDOI10.1007/s40264-013-0130-y